Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  ICo Therapeutics Inc    ICO   CA45107J1057

ICO THERAPEUTICS INC

(ICO)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ICO THERAPEUTICS INC
04/22/20 FY 2019 Earnings Release (Projected)
05/28/20 Q1 2020 Earnings Release (Projected)
06/03/21 Q1 2021 Earnings Release (Projected)
Past events on ICO THERAPEUTICS INC
06/27/19 | 01:00pm Annual General Meeting
05/30/19 Q1 2019 Earnings Release
04/30/19 FY 2018 Earnings Release
09/06/18 | 03:50pm Rodman & Renshaw Global Investment Conference
Upcoming sector events for ICO THERAPEUTICS INC
09/18/19 QIAGEN NV : Bank of America Merrill Lynch Global Health Care Conference
09/18/19 | 07:10am INCYTE CORPORATION : Bank of America Merrill Lynch Global Health Care Conference
09/18/19 | 09:30am BLUEBIRD BIO INC : European Pediatric Neurology Society Congress - Phase 2/3 Trial to Assess the Safety and Efficacy
09/18/19 | 09:30am BLUEBIRD BIO INC : European Pediatric Neurology Society Congress - An observational study of outcomes of Allogeneic Hem
More events
Past sector events for ICO THERAPEUTICS INC
09/14/19 | 06:00pm IONIS PHARMACEUTICALS INC : Heart Failure Society of America Scientific Meeting
09/14/19 | 06:15pm ALNYLAM PHARMACEUTICALS, INC. : Heart Failure Society of America Scientific Meeting - Identifying Mixed Phenotype
09/14/19 | 06:15pm ALNYLAM PHARMACEUTICALS, INC. : Heart Failure Society of America Scientific Meeting - Risk Factors for Mortality in Patients with He
09/16/19 | 01:00pm ALNYLAM PHARMACEUTICALS, INC. : Investor Meeting - Patisiran & Vutrisiran, for the Treatment of Transthyretin-Mediated Amyloidosis
Annual publications
Annual results20132014
Sales
M CAD
Released
Forecast
Spread




Operating income
(EBITDA)
M CAD
Released
Forecast
Spread
-6,27
-6,49
3,4%
-2,22

Operating profit
(EBIT)
M CAD
Released
Forecast
Spread
-6,36
-7,36
14%
-2,27
-3,04
25%
Pre-Tax Profit
(EBT)
M CAD
Released
Forecast
Spread
-5,67
-6,72
16%


Net income
M CAD
Released
Forecast
Spread
-5,67
-6,72
16%


EPS
 CAD
Released
Forecast
Spread
-0,09
-0,11
18%


Announcement Date04/24/201404/27/2015

Assessed data source
© 2019 S&P Global Market Intelligence
© 2019 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise